Try our Advanced Search for more refined results
February 20, 2013
Track this case
2:13-cv-01028
New Jersey
Patent
Susan D. Wigenton
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Novartis Pharmaceuticals Corp. filed a lawsuit Wednesday in New Jersey federal court seeking to bar more than a dozen drugmakers from making generic versions of its osteoporosis drug Reclast and oncology drug Zometa.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.